Latest news
SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs - Manufacturing ChemistManufacturing Chemist · Thu, 06 Aug 2026 14:39:46 GMTTasrif Pharmaceutical granted second US patent for CD155-targeting antibody developed with Abzena's humanisation and immunogenicity platforms - Manufacturing ChemistManufacturing Chemist · Tue, 04 Aug 2026 12:14:55 GMTPromatix secures Innovate UK grant to advance cis-bispecific ADC programme - Manufacturing ChemistManufacturing Chemist · Tue, 04 Aug 2026 12:14:55 GMTParsortix CTC platform detects ADC targets in breast and ovarian cancer - Manufacturing ChemistManufacturing Chemist · Mon, 03 Aug 2026 12:37:56 GMT